HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative Selected Research

European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative Research Topics

Disease

4Atherosclerosis
01/2020 - 07/2016
3Hypertriglyceridemia
01/2020 - 01/2018
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2020
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
07/2016
1Homozygous Familial Hypercholesterolemia
07/2016
1Pancreatitis
07/2016

Drug/Important Bio-Agent (IBA)

4LDL CholesterolIBA
01/2020 - 07/2016
3Lipoproteins (Lipoprotein)IBA
01/2020 - 01/2018
3LipidsIBA
01/2020 - 07/2016
3HDL CholesterolIBA
01/2020 - 01/2018
3Triglycerides (Triacylglycerol)IBA
01/2020 - 07/2016
2Apolipoproteins B (ApoB)IBA
01/2020 - 01/2018
2CholesterolIBA
01/2020 - 01/2020
2ApolipoproteinsIBA
01/2020 - 01/2020
2oxidized low density lipoproteinIBA
01/2020 - 01/2020
1Lipoprotein(a)IBA
07/2016